Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Crescent Biopharma Inc
F:C68
Crescent Biopharma Inc
F:C68
Price:
12.1
EUR
-1.63%
Market Cap:
€168.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Crescent Biopharma Inc
F:C68
|
US |
|
UiPath Inc
F:9UV
|
US |
Wall St Price Targets
C68 Price Forecast
Based on 8 analysts
Based on 8 analysts
+25% Upside
from
€12.1
today
Crescent Biopharma Inc (C68)’s 12-month stock price forecast through October 2027 has a consensus target of €15.16, implying 25% upside. The forecast is based on price targets from 8 Wall Street analysts.
C68 Analyst Rating
No ratings yet
No ratings yet
Crescent Biopharma Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is C68's stock price target?
Price Target
15.16
EUR
15.16
EUR
According to Wall Street analysts, the average 1-year price target for C68 is 15.16 EUR with a low forecast of 14.47 EUR and a high forecast of 19.5 EUR.
What is the Revenue forecast for Crescent Biopharma Inc?
Projected CAGR
77%
77%
Over the last 13 years, the compound annual growth rate for Revenue has been -3%. The projected CAGR for the next 8 years is 77%.